Recent news on Pancrelipase

Digestive Care, Inc. Announces Expansion of PANCRECARB(R ...  -  May 16, 2007
PR Newswire (press release),...facility in order to meet the growing demand for PANCRECARB(R) (pancrelipase), a pancreatic enzyme for the treatment of pancreatic insufficiency.

Axcan Pharma Continues Solid Growth in Fiscal 2007, With Record ...  -  May 10, 2007
SYS-CON Media,Axcan is developing NMK 150, a new high protease pancrelipase preparation developed for the relief of pain in small duct chronic pancreatitis,

Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue ...  -  Feb 8, 2007
Genetic Engineering News (press release),Axcan is developing NMK 150, a new high protease pancrelipase preparation developed for the relief of pain in small duct chronic pancreatitis,

MLK Jr. essay winners announced  -  Jan 17, 2007
Lexington Herald Leader,He receives $2000 per year for up to two years of study and a year's supply of Creon Minimicrospheres (pancrelipase delayed-release capsules,

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  Nov 30, 2006
Genetic Engineering News (press release),Axcan and Nordmark GmbH, a German pharmaceutical firm, are collaborating in the development of NMK 150, a new high protease pancrelipase preparation

Axcan Pharma Closes Fiscal 2006 with Record Annual Revenue of ...  -  12 Dec 2006
Genetic Engineering News (press release),Axcan and Nordmark GmbH, a German pharmaceutical firm, are collaborating in the development of NMK 150, a new high protease pancrelipase preparation

Solvay Pharmaceuticals settles lawsuit against pseudo-generics to ...  Aug 10, 2006
...and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals' Creon Minimicrospheres (pancrelipase delayed-release capsules ... -Therapeutics Daily (subscription)

Axcan Announces Strong Third Quarter 2006 Revenue of $76.7 Million ...  Aug 10, 2006
Axcan and Nordmark GmbH, a German pharmaceutical firm, are collaborating in the development of NMK 150, a new high protease pancrelipase preparation developed ... -Market Wire

Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to ...  Jul 11, 2006
...and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals' CREON(R) MINIMICROSPHERES(R) (Pancrelipase Delayed-release ... -PharmaLive.com

Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to  Jul 12, 2006
...and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals' CREON® MINIMICROSPHERES® (Pancrelipase Delayed-release ... -Companynewsgroup (Comunicados de prensa)



Axcan announces record revenue of $72.8 million for the second ...  May 4, 2006
Axcan and Nordmark GmbH, a German pharmaceutical firm, are collaborating in the development of NMK 150, a new high protease pancrelipase preparation developed ... - Yahoo! News





Axcan announces record revenue of $70.6 million for the first ...  09 Feb 2006
Axcan and Nordmark GmbH, a German pharmaceutical firm, are collaborating in the development of NMK 150, a new high protease pancrelipase preparation developed ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional